Retina transplants via donor iPS cells

Retina transplants via donor iPS cells

Masayo Takahashi, a researcher at the Japanese government-backed Riken institute, speaks at an academic conference in Tokyo on April 18, 2019. Five patients suffering a severe eye disease were doing well a year after they received in 2017 the world's first transplant surgeries using induced pluripotent stem cells from donors, she said. (Kyodo) ==Kyodo

  • Product Code
  • ILEA000156065
  • Registered date
  • 2019/4/18 11:54:57
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2019 Kyodo News
  • Media size
  • 2015 × 2353 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 683.60(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    World's 1st transplant of iPS heart muscle tissue

    World's 1st transplant of iPS heart muscle tissue

    Osaka University professor Yoshiki Sawa (L) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
      World's 1st transplant of iPS heart muscle tissue

      World's 1st transplant of iPS heart muscle tissue

      Osaka University professor Yoshiki Sawa (R) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
        World's 1st transplant of iPS heart muscle tissue

        World's 1st transplant of iPS heart muscle tissue

        Osaka University professor Yoshiki Sawa attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
          World's 1st transplant of iPS heart muscle tissue

          World's 1st transplant of iPS heart muscle tissue

          Osaka University professor Yoshiki Sawa attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
            World's 1st transplant of iPS heart muscle tissue

            World's 1st transplant of iPS heart muscle tissue

            Osaka University professor Yoshiki Sawa (C) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
              World's 1st transplant of iPS heart muscle tissue

              World's 1st transplant of iPS heart muscle tissue

              Osaka University professor Yoshiki Sawa (C) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
                Renowned researcher leaves Riken institute

                Renowned researcher leaves Riken institute

                Photo taken Nov. 10, 2017, shows Masayo Takahashi, a researcher at the Japanese government-backed Riken institute who led a team that succeeded for the first time in the world in transplanting into a woman retinal cells grown from her own iPS cells in 2014. Riken announced on July 31, 2019, that Takahashi will leave the institute the same day. (Kyodo) ==Kyodo
                  Retina transplants via donor iPS cells

                  Retina transplants via donor iPS cells

                  Photo taken Nov. 10, 2017, shows Masayo Takahashi, a researcher at the Japanese government-backed Riken institute. She said in Tokyo on April 18, 2019 that five patients suffering a severe eye disease were doing well a year after they received in 2017 the world's first transplant surgeries using induced pluripotent stem cells from donors. (Kyodo) ==Kyodo
                    World's 1st test using iPS cells to treat corneal disease

                    World's 1st test using iPS cells to treat corneal disease

                    Osaka University professor Koji Nishida speaks at a press conference in Tokyo on March 5, 2019, about the world's first clinical test to treat patients with a corneal disease by using artificially derived stem cells. (Kyodo) ==Kyodo
                      World's 1st test using iPS cells to treat corneal disease

                      World's 1st test using iPS cells to treat corneal disease

                      Osaka University professor Koji Nishida (2nd from R) speaks at a press conference in Tokyo on March 5, 2019, about the world's first clinical test to treat patients with a corneal disease by using artificially derived stem cells. (Kyodo) ==Kyodo